ValiRx - Acquisition of Intellectual Property & JV Agreement
VAL Thu, 02 May 2019, 01:16pm BST
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Industry: Health Care
Contact: +44 (0)2476 796496
Dr George Morris, COO of ValiRx discusses the acquisition of IP assets of FIT Biotech OY and the signing of the LOI agreement with investor, Alpha Blue Ocean to establish a genetic therapeutic and diagnostic-based Joint Venture.